Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

GSK 2248761

Known as: GSK-2248761, GSK2248761 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
BACKGROUND Fosdevirine (GSK2248761) is a non-nucleoside reverse transcriptase inhibitor with HIV-1 activity against common… Expand
  • figure 1
  • figure 1
  • figure 2
  • table 1
  • figure 3
2013
2013
The CNS disposition and metabolism of Fosdevirine (FDV), an HIV non-nucleoside reverse transcriptase inhibitor, was investigated… Expand
2012
2012
AIM To evaluate potential drug interactions with antiretroviral therapies or supportive therapies for use in conjunction with the… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
2012
2012
ABSTRACT GSK2248761 is a novel, once-daily (QD), next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) with… Expand
  • table 1
  • figure 1
  • figure 2
  • table 3
Review
2010
Review
2010
Antiretroviral drug resistance is one of the complications of highly active antiretroviral therapy (HAART). Second-generation non… Expand